Head-to-Head Trials: Olanzapine Versus Lithium

In this episode, we challenge conventional prescribing by exploring why lithium should be the first-line treatment for acute classic mania, despite widespread use of antipsychotics. Dr. David Osser presents evidence-based arguments for lithium's unique neuroprotective benefits and long-term efficacy.

Faculty: David Osser, M.D. Host: Richard Seeber, M.D.

• Learn more about our memberships here
• Earn 1.5 CME: An Update on Bipolar Mania Algorithm
• Lithium for Bipolar Mania Without Mixed Features